British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

Ohio and Indiana are suing the makers of a popular heartburn medication, saying the drug company concealed cancer risks and ...

London stocks fell sharply on Wednesday, with investors reacting to heightened geopolitical tensions after China unveiled ...

London stocks had extended losses by midday on Wednesday as Trump’s sweeping tariffs came into force, including a swingeing ...

Pfizer denied the allegations and argued GSK's patents were invalid. It convinced a London court to invalidate related UK patents owned by GSK in a separate case last year. GSK has also sued ...

The FTSE 100 tumbled 2.92 percent on Wednesday, shedding 231.05 points to close at 7,679.48 points as U.S. President ...

Oil and pharmaceutical companies bore the brunt of heavy selling as the FTSE 100 index and other European bourses fell ...

The Dow and S&P 500 wavered between gains and losses at midday Wednesday amid heightened volatility after the U.S. imposed ...

LONDON: European stock markets sank on Wednesday (Apr 9) as US President Donald Trump's steep new tariffs came into effect ...

Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...

ABL Bio Inc. sealed a potential £2.075 billion (US$2.65 billion) license deal with GSK plc, granting GSK global rights to use ABL’s blood-brain barrier penetrating bispecific antibody platform, ...